The ORGALUTRAN brand, founded in 1998 (Netherlands), from
402 sister brands
and 17477 competing brands.
ORGALUTRAN is owned by Merck & Co, listed on the stock exchange of New York
ORGALUTRAN is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.